# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-000333
Filing Date
2023-01-06
Accepted
2023-01-06 16:11:41
Documents
4
Period of Report
2023-02-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rkda-def14a_reversestock.htm | DEF 14A | 512452
2 | GRAPHIC | img248061859_0.jpg | GRAPHIC | 49571
3 | GRAPHIC | img248061859_1.jpg | GRAPHIC | 435250
4 | GRAPHIC | img248061859_2.jpg | GRAPHIC | 306309
| Complete submission text file | 0000950170-23-000333.txt |  | 1543879

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37383 | Film No.: 23515179
SIC: 0100 Agricultural Production-Crops